05/23/2024 4:00 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/13/2024 6:01 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/22/2024 12:06 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024 6:29 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 6:03 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/05/2024 11:18 AM | BlackRock Inc. (Filed by) Legend Biotech (Subject)
| Form SC 13G/A | |
03/29/2024 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
03/26/2024 4:22 PM | Ji Darren Xiaohui (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/25/2024 3:57 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 10:09 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
03/19/2024 6:57 AM | Legend Biotech (Filer)
| Form F-3ASR | |
03/19/2024 6:02 AM | Legend Biotech (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
03/15/2024 2:18 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/13/2024 7:36 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/11/2024 6:52 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/28/2024 5:46 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144/A | |
02/28/2024 4:35 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/27/2024 6:47 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 12:10 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/23/2024 6:16 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/14/2024 7:34 PM | GenScript Biotech Corp (Filed by) Legend Biotech (Subject)
| Form SC 13G/A | |
01/29/2024 4:25 PM | BlackRock Inc. (Filed by) Legend Biotech (Subject)
| Form SC 13G | |
01/23/2024 8:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/23/2024 6:30 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 9:00 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 2:38 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/22/2023 2:21 PM | Legend Biotech (Subject) Macomber Lori (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/21/2023 4:17 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/12/2023 1:31 PM | Heyman Tomas J. (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
11/20/2023 5:02 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023 7:30 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/17/2023 4:39 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/17/2023 4:50 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144/A | |
10/17/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/16/2023 4:20 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/27/2023 11:02 AM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/25/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/22/2023 3:10 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/22/2023 3:20 PM | Legend Biotech (Subject) Macomber Lori (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
09/18/2023 3:41 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/28/2023 9:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
This military-backed stock “owns” AI market (Ad) The AI boom is just getting started.
And the real wealth has still to be made… You must read this new presentation from Porter Stansberry. |
08/23/2023 3:27 PM | Legend Biotech (Subject) Sanders Corazon D. (0001796536) (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023 5:10 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/20/2023 7:00 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/26/2023 9:30 AM | Legend Biotech (Subject) Yau Wai Man Philip (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2023 12:45 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/06/2023 3:44 PM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/06/2023 2:00 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/05/2023 10:17 AM | Legend Biotech (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/01/2023 3:18 PM | Huang Ying (Reporting) Legend Biotech (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |